KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro

Bitget2026/11/04 12:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

KKR-managed funds, Hildred and EQT Life Sciences are investing new capital in Onvaro to support its growth.
Formed through the combination of Sapphiros and binx health, Onvaro develops diagnostics for health care and consumer settings.
The investment will support commercial expansion and development of decentralized testing products.
Onvaro's commercial portfolio centers on the binx io molecular point-of-care platform, with more than 1,000 installed instruments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KKR & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104492716) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro

You may also like

Crypto prices